Abstract
Full text links
Read article at publisher's site: https://doi.org/10.1016/s1074-7613(00)00055-8
Read article for free, from open access legal sources, via Unpaywall: http://www.cell.com/article/S1074761300000558/pdf
References
Articles referenced by this article (30)
Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12.
J Exp Med, (1):399-404 1995
MED: 7528775
Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.
Science, (5164):1415-1421 1994
MED: 8197455
Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease.
Cell, (3):443-450 1996
MED: 8608598
IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes.
J Immunol, (3):1079-1090 1995
MED: 7543512
tyk2, prototype of a novel class of non-receptor tyrosine kinase genes.
Oncogene, (9):1329-1336 1990
MED: 2216457
A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6.
EMBO J, (7):1421-1429 1995
MED: 7537214
Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4.
J Exp Med, (5):1755-1762 1995
MED: 7722452
Show 10 more references (10 of 30)
Citations & impact
Impact metrics
Citations of article over time
Alternative metrics
Article citations
Validation of TYK2 and exploration of PRSS36 as drug targets for psoriasis using Mendelian randomization.
Sci Rep, 14(1):23902, 13 Oct 2024
Cited by: 0 articles | PMID: 39397091 | PMCID: PMC11471773
Tyrosine kinase 2 modulates splenic B cells through type I IFN and TLR7 signaling.
Cell Mol Life Sci, 81(1):199, 29 Apr 2024
Cited by: 1 article | PMID: 38683377 | PMCID: PMC11058799
Identification of common genes and pathways between type 2 diabetes and COVID-19.
Front Genet, 15:1249501, 18 Apr 2024
Cited by: 1 article | PMID: 38699234 | PMCID: PMC11063347
TYK2 signaling promotes the development of autoreactive CD8+ cytotoxic T lymphocytes and type 1 diabetes.
Nat Commun, 15(1):1337, 13 Feb 2024
Cited by: 1 article | PMID: 38351043 | PMCID: PMC10864272
Application of JAK inhibitors in paradoxical reaction through immune-related dermatoses.
Front Immunol, 15:1341632, 20 Feb 2024
Cited by: 1 article | PMID: 38444845
Review
Go to all (194) article citations
Other citations
Data
Similar Articles
To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.
Partial impairment of cytokine responses in Tyk2-deficient mice.
Immunity, 13(4):549-560, 01 Oct 2000
Cited by: 247 articles | PMID: 11070173
Tyk2 negatively regulates adaptive Th1 immunity by mediating IL-10 signaling and promoting IFN-gamma-dependent IL-10 reactivation.
J Immunol, 176(12):7263-7271, 01 Jun 2006
Cited by: 73 articles | PMID: 16751369
Partial impairment of interleukin-12 (IL-12) and IL-18 signaling in Tyk2-deficient mice.
Blood, 99(6):2094-2099, 01 Mar 2002
Cited by: 44 articles | PMID: 11877284
Therapeutic Advantage of Tyk2 Inhibition for Treating Autoimmune and Chronic Inflammatory Diseases.
Biol Pharm Bull, 44(11):1585-1592, 01 Jan 2021
Cited by: 7 articles | PMID: 34719635
Review
Funding
Funders who supported this work.